Period of time： 2014年6期
Publisher： Informa Healthcare
Founded in： 2002
Total resources： 54
ISSN： 1474-0338
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Safety,volume 5,issue 6
Menu
Safety issues associated with the use of angiotensin-converting enzyme inhibitors
Expert Opinion on Drug Safety,volume 5,issue 6 , Vol. 5, Iss. 6, 2006-11 , pp.
Access to resources
Recommend
Topiramate-induced psychosis: report of two cases
By Teive Hélio AG,Arruda Walter Oleschko,Munhoz Renato P,Werneck Lineu C in (2006)
Expert Opinion on Drug Safety,volume 5,issue 6 , Vol. 5, Iss. 6, 2006-11 , pp.Osteonecrosis of the jaw: what do bisphosphonates do?
Expert Opinion on Drug Safety,volume 5,issue 6 , Vol. 5, Iss. 6, 2006-11 , pp.Safety and risk communication to patients
Expert Opinion on Drug Safety,volume 5,issue 6 , Vol. 5, Iss. 6, 2006-11 , pp.By Mena Maria A,de Yébenes Justo G in (2006)
Expert Opinion on Drug Safety,volume 5,issue 6 , Vol. 5, Iss. 6, 2006-11 , pp.The safety of dental amalgam in children
By Martin Michael D,Woods James S in (2006)
Expert Opinion on Drug Safety,volume 5,issue 6 , Vol. 5, Iss. 6, 2006-11 , pp.Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use
By Passàli Desiderio,Salerni Lorenzo,Passàli Giulio Cesare,Passàli Francesco Maria,Bellussi Luisa in (2006)
Expert Opinion on Drug Safety,volume 5,issue 6 , Vol. 5, Iss. 6, 2006-11 , pp.By Jones Robin L,Swanton Charles,Ewer Michael S in (2006)
Expert Opinion on Drug Safety,volume 5,issue 6 , Vol. 5, Iss. 6, 2006-11 , pp.Risk of atrial fibrillation with high-dose corticosteroids
By Chiappini Bruno,El Khoury Gebrine in (2006)
Expert Opinion on Drug Safety,volume 5,issue 6 , Vol. 5, Iss. 6, 2006-11 , pp.
Previous
Next